Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal — Head of Investor Relations Parag Agarwal — Chief Financial Officer Erez Israeli — Chief Executive Officer Analysts: Shanti Patel — Shanti Patel Investment Advisors — Analyst Rashmi Sancheti — InCred Research — Analyst Damayanti Kerai — HSBC Securities and Capital Markets — Analyst Kunal Dhamesha — Emkay Global Financial Services...
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Related Post
- Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors,…
-
Pfizer affirms FY25 earnings guidance, provides full-year 2026 outlook
Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue…
-
Everything you need to know about Medline’s IPO
After a modest start to the year, IPO activity rebounded in the second half of…